Humana Inc. $HUM Stock Position Lessened by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 37,695 shares of the insurance provider’s stock after selling 1,603 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Humana were worth $6,483,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Stephens Inc. AR lifted its stake in shares of Humana by 17.2% in the 1st quarter. Stephens Inc. AR now owns 1,434 shares of the insurance provider’s stock worth $249,000 after acquiring an additional 210 shares during the period. V Square Quantitative Management LLC increased its stake in shares of Humana by 19.2% during the first quarter. V Square Quantitative Management LLC now owns 3,650 shares of the insurance provider’s stock valued at $633,000 after acquiring an additional 588 shares during the period. HB Wealth Management LLC raised its holdings in Humana by 13.1% during the first quarter. HB Wealth Management LLC now owns 4,517 shares of the insurance provider’s stock worth $783,000 after purchasing an additional 522 shares in the last quarter. New York State Teachers Retirement System raised its holdings in Humana by 0.5% during the first quarter. New York State Teachers Retirement System now owns 94,164 shares of the insurance provider’s stock worth $16,327,000 after purchasing an additional 513 shares in the last quarter. Finally, Leonteq Securities AG lifted its position in Humana by 185.8% in the first quarter. Leonteq Securities AG now owns 8,196 shares of the insurance provider’s stock worth $1,421,000 after purchasing an additional 5,328 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on HUM shares. Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. TD Cowen raised their target price on Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research note on Friday, May 1st. JPMorgan Chase & Co. lifted their target price on Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a report on Monday, June 8th. Finally, Cantor Fitzgerald boosted their price target on shares of Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 7th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $303.74.

Humana Price Performance

Shares of NYSE HUM traded down $5.00 during trading on Friday, hitting $392.76. The company had a trading volume of 1,788,183 shares, compared to its average volume of 1,385,265. The company has a market cap of $47.16 billion, a P/E ratio of 42.01, a PEG ratio of 2.24 and a beta of 0.71. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $415.00. The business’s 50-day moving average is $338.80 and its 200 day moving average is $255.19. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Equities research analysts predict that Humana Inc. will post 9.03 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio is currently 37.86%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.